Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo-Rama Synthetics Tbk. (INDR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Indo-Rama Synthetics Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo-Rama Synthetics Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo-Rama Synthetics Tbk. trades at Rp2,420 (market cap 1.58T, 14.7K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 2.5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 14.7K). Which is the better fit depends on your goals.

INDRLABS
Market Cap
1.58T635.95B
Volume
14.7K843K
Lot
1478.43K
Turnover
34.64M137.6M
Average Price
2,356.26163.22
Value
34.64M137.6M
Indicative Equilibrium Price
2,380165
Indicative Equilibrium Volume
2246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INDR
View details
LABS
View details

About Indo-Rama Synthetics Tbk.

PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.

Read more on INDR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS